Research demonstrates selectivity and high U(VI) adsorption using organic-embedded mesoporous silica, indicating effective radionuclide management.
In this research, an in-situ encapsulation strategy for constructing two organic-embedded mesoporous silica spheres (OMSS-1 and OMSS-2) is presented, which achieves efficient U(VI) extraction from solution. By confining L-aspartic acid or citric acid within mesochannels (2.52 nm) during self-assembly, the composites attain exceptional U(VI) affinity. The OMSS-1 and OMSS-2 exhibit high U(VI) adsorption capacities of 172.4 and 188.3 mg/g. The adsorption isothermal and kinetic models are carried out to study the adsorption of U(VI) on the composites. The adsorption processes of U(VI) on OMSS-1 and OMSS-2 are in accordance with Langmuir model and the pseudo-second-order model. Crucially, aspartate-embedded spheres (OMSS-1) demonstrate excellent selectivity in multicomponent systems containing 13 competing ions. The confinement-stabilized ligands enable outstanding regenerability, retaining >93 % capacity over 5 adsorption-desorption cycles with minimal leaching (<0.8 wt%/cycle). This work provides a reference for the design and synthesis of advanced adsorption materials by reconciling the traditionally conflicting objectives of high capacity, specificity, and stability in radionuclide management.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: